“两票制”的出台,意味着对药品流通环节将形成有效监督。但“谁来养医”这一症结仍需真正解开。1月9日,备受外界关注的“两票制”政策正式对外公布。国家卫计委今年将在11个综合医改试点省和200个公立医院改革试点城市全力推进,争取2018年全国推开。“两票制”是指药品从生产企业到流通企业开一次发票,流通企业到医疗机构开一次发票,目的是减少 “Two votes system ” The introduction, means that the drug circulation will form an effective supervision. But “Who is going to support medicine,” the crux still needs to be truly solved. On January 9, much attention from the public was promulgated by the “two-vote system” policy. This year, the National Health Planning Commission will make every effort to promote pilot cities in 11 pilot comprehensive medical reform projects and 200 public hospitals, and strive for a nationwide push through 2018. “Two votes system ” refers to the drug from the manufacturer to the circulation of enterprises to open an invoice, circulation companies to medical institutions to open an invoice, the purpose is to reduce